 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $34.118,02 | (27/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $15.946,86 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $14.718,08 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $42.166,23 | (27/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $18.478,74 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $17.910,91 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $44.437,73 | (27/01/26) |
| PAMI |
|
| AF $17.460,04 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $19.374,50 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $44.709,10 | (27/01/26) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $28.881,88 | (27/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $12.389,83 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $11.122,88 |
|
|
|
|
| |
